EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study

Kai Kaarniranta iD, Mikko Valtanen, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto, Jaana Lindström iD, Matti Uusitupa

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae287 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Kai Kaarniranta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Sciences, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Sigrid Juselius Foundation, Finnish Eye Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Lifestyle intervention reduces the incidence of type 2 diabetes (T2D) in people with impaired glucose tolerance (IGT).

Objective

This work aimed to find out whether participation in an earlier lifestyle intervention had an effect on the occurrence of clinically diagnosed diabetic retinopathy (DR) during a median of 22 years of follow-up time.

Methods

The study included 505 individuals from the Finnish Diabetes Prevention Study (DPS) (mean age 55; range, 40-64 years at the onset of the study) with IGT who were originally randomly assigned to the intervention (weight loss, healthy diet, and physical activity) (N = 257) and usual care control groups (N = 248). The median follow-up was 22 years. Clinical retinopathy diagnoses were obtained from the Finnish national hospital Care Register for Health. Data on glycemic parameters, serum lipids, and blood pressure were available from both the intervention (median 4 years) and postintervention period (until year 7).

Results

No significant difference was found in the cumulative incidence of clinically diagnosed DR between the original intervention (N = 23, 8.9%) and control groups (N = 19, 7.7%) during the extended follow-up (odds ratio: 1.15; 95% CI, 0.61-2.21). A higher cumulative glycated hemoglobin A1c (HbA1c) was significantly associated with a higher risk of retinopathy (hazard ratio 1.4; 1.02-1.88, 95% posterior interval, adjusted for group, age, and sex). Furthermore, the incidence of retinopathy diagnosis was numerically more common among individuals who had developed diabetes during the follow-up (33/349) compared with those who had not (9/156); however, the comparison was not statistically significant (odds ratio: 1.86, 95% CI, 0.89-4.28, adjusted for group, age, and sex).

Conclusion

A higher cumulative HbA1c was significantly associated with a higher risk of retinopathy. No evidence was found for a beneficial effect of a 4-year lifestyle intervention on the long-term occurrence of clinical DR during a median of 22-year follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDiabetes Mellitus, Type 2HumansFinlandMaleMiddle AgedFemaleIncidenceAdultFollow-Up StudiesGlucose IntoleranceGlycated HemoglobinLife StyleRisk FactorsDiet, HealthyExercise

Stichwörter der Autor:innen

HbA1cdiabetesglucoselifestyle interventionpreventionretinopathy

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Institute of Medical Sciences, School of Medicine, University of Eastern Finland, 70211 Kuopio, Finland.
  • Department of Ophthalmology, Kuopio University Hospital, 70029, Kuopio, Finland.
  • Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland.
  • Department of Chronic Disease Prevention, National Institute for Health and Welfare, 00271 Helsinki, Finland.
  • Center for Life Course Health Research, University of Oulu, 90014 Oulu, Finland.
  • Department of Public Health, University of Helsinki, 00014 Helsinki, Finland.

ORCID-Profile: Kai Kaarniranta, Jaana Lindström

Förderung

  • Academy of Finland
  • Sigrid Juselius Foundation
  • Finnish Eye Foundation

Zitieren

APA

Kaarniranta, K., Valtanen, M., Keinänen-Kiukaanniemi, S., Tuomilehto, J., Lindström, J., & Uusitupa, M. (2025). Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae287

Vancouver

Kaarniranta K, Valtanen M, Keinänen-Kiukaanniemi S, Tuomilehto J, Lindström J, Uusitupa M. Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae287

BibTeX
@article{Kaarniranta2025,
  author = {Kaarniranta, Kai and Valtanen, Mikko and Keinänen-Kiukaanniemi, Sirkka and Tuomilehto, Jaakko and Lindström, Jaana and Uusitupa, Matti},
  title = {Long-term Cumulative Incidence of Clinically Diagnosed Retinopathy in the Finnish Diabetes Prevention Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae287}
}
Kostenlos starten →